ATRO
Astronics Corporation
ATRO has the edge over CAT overall, supported by stronger valuation and stronger fundamentals.
CAT
Caterpillar Inc.
CAT has lower modeled downside risk, despite its lower overall score.
ATRO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Healthy |
ATRO's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
ATRO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.7x | $25.97 | -57% |
| Current | 20x | $60.31 | — |
| Fair | 41x | $121 | +101% |
| Expensive | 84x | $251 | +316% |
Historical ranges are pointers, not guarantees.
ATRO's PE is in its fair range at 20x.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over ATRO in the historical PE scenario, which offers more potential upside but is not a forecast.
ATRO Forward outlook
There aren't enough analyst estimates for ATRO to show an outlook.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
ATRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.99 | +$3.06 |
| Q2 2026 | $1.66 | +$1.76 |
| Q1 2026 | $0.94 | +$1.04 |
| Q4 2025 | $0.61 | +$0.99 |
| Q3 2025 | -$0.07 | +$0.08 |
| Q2 2025 | -$0.10 | +$0.19 |
| Q1 2025 | -$0.10 | +$0.51 |
| Q4 2024 | -$0.38 | +$0.27 |
ATRO has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
ATRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $271.7M | +28% |
| Q2 2026 | $260M | +27% |
| Q1 2026 | $230.6M | +12% |
| Q4 2025 | $240.1M | +15% |
| Q3 2025 | $211.4M | +3.8% |
| Q2 2025 | $204.7M | +3.3% |
| Q1 2025 | $205.9M | +11% |
| Q4 2024 | $208.5M | +6.8% |
ATRO's revenue has grown year over year for 21 quarters in a row: $272M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +9 points |
| Q2 2026 | 16% | +13 points |
| Q1 2026 | 12% | +5.4 points |
| Q4 2025 | 15% | +11 points |
| Q3 2025 | 11% | +6.8 points |
| Q2 2025 | 2.3% | -1.5 points |
| Q1 2025 | 6.4% | +5.5 points |
| Q4 2024 | 4.3% | +0.3 points |
ATRO's operating margin was 20% last quarter, up 9 points from the same quarter a year ago, near the top of its range since 2019.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over ATRO on profitability, with a higher operating margin.
ATRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.6M | +3% |
| Q2 2026 | $24.4M | +$36.6M |
| Q1 2026 | -$554K | -103% |
| Q4 2025 | $15.8M | -32% |
| Q3 2025 | $21M | +222% |
| Q2 2025 | -$12.2M | -$4.2M |
| Q1 2025 | $18.5M | +4123% |
| Q4 2024 | $23.2M | +$26.5M |
ATRO has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
ATRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.3% | +2M shares |
| 1 year | +9.3% | +4.1M shares |
| 3 years | +17% | +7.2M shares |
| 5 years | +25% | +9.7M shares |
| Available history | +19% | +7.9M shares |
ATRO has 49M diluted shares, up 9.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $7.7M |
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over ATRO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
ATRO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 2.0x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 4.5x | High |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 3.1x | Elevated |
ATRO's net debt is about 1.5 years of its operating earnings (EBITDA), down from 4.5 years a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over ATRO on leverage, with a lower net debt burden relative to earnings.
ATRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 11.4 | Oversold |
ATRO's weekly RSI is 45 (neutral) and its Stochastic is 11 (oversold).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ATRO PE vs Industrials Sector
| Metric | ATRO | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 24x | 16% below |
| PE % | 38 | 58 | 20 pts below |
ATRO has the edge over CAT on valuation relative to its sector.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
ATRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.9 | 2.6% below |
| 20 week MA | $69.3 | 13% below |
| 50 week MA | $63.1 | 4.5% below |
| 100 week MA | $44.1 | 37% above |
| 200 week MA | $29.0 | 108% above |
ATRO has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 108% above its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
ATRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.5 | $10.4 | -54% |
| 2021 | $10.4 | $9.34 | -11% |
| 2022 | $9.34 | $7.57 | -19% |
| 2023 | $7.57 | $13.9 | +84% |
| 2024 | $13.9 | $12.8 | -8% |
| 2025 | $12.8 | $44.2 | +246% |
| 2026 YTD | $44.2 | $60.3 | +36% |
ATRO has the edge over CAT on returns for 2026, with the stronger performance.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.